Ropes & Gray advised MACOM on the deal, and Smith Anderson advised Wolfspeed. MACOM Technology Solutions Holdings, Inc. (NASDAQ: MTSI) announced that it has entered into a...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Tecomet on the refinancing. Tecomet announced the refinancing of its capital structure to provide the company with increased operational and financial flexibility....
You must be a Standard 1 Year member to access this content.
Morgan, Lewis & Bockius acted as legal counsel to Eli Lilly, and Ropes & Gray acted as legal counsel to Sigilon. Eli Lilly and Company (NYSE:...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised National Amusements Inc. on the deal. National Amusements, Inc, the majority voting shareholder of Paramount Global, announced that it has entered into...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Charlesbank Capital Partners LLC and its portfolio company, BOX Partners on the deal. Charlesbank Capital Partners LLC and its portfolio company, BOX...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Charlesbank Capital Partners and Salus GRC on the deal. Charlesbank Capital Partners (“Charlesbank”) announced that it has entered into a partnership with...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented America’s Test Kitchen Limited Partnership on the deal. Latham & Watkins and Greenberg Traurig represented Marquee Brands. America’s Test Kitchen Limited Partnership...
You must be a Standard 1 Year member to access this content.
Pillsbury Winthrop Shaw Pittman LLP advised NEUCA Group on the deal while Ropes & Gray advised Moffitt Cancer Center and OncoBay Clinical. NEUCA Group, the parent...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Scipher Medicine on the deal. Precision immunology company Scipher Medicine announced its acquisition of data, analytics and software company CrossBridge to enhance...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Moffitt Cancer Center and OncoBay Clinical on the deal. OncoBay obtained an investment from Clinscience, a global clinical research organization based in Warsaw,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Xeris Biopharma on the deal. Xeris Biopharma announced a research collaboration and option agreement with Horizon Therapeutics. Under the agreement announced on November...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Audax Private Equity, while Dechert advised DISA Global Solutions in the deal. Audax Private Equity executed its acquisition of DISA Global Solutions,...
You must be a Standard 1 Year member to access this content.
